Table: begin end state 1 20 cytoplasmic 21 40 transmembrane 41 45 non-cytoplasmic 46 63 transmembrane 64 98 cytoplasmic 99 121 transmembrane 122 125 non-cytoplasmic 126 144 transmembrane 145 153 cytoplasmic 154 175 transmembrane 176 197 non-cytoplasmic 198 219 transmembrane 220 239 cytoplasmic 240 261 transmembrane 262 273 non-cytoplasmic 274 299 transmembrane 300 330 cytoplasmic 331 353 transmembrane 354 358 non-cytoplasmic 359 378 transmembrane 379 398 cytoplasmic 399 421 transmembrane 422 426 non-cytoplasmic 427 445 transmembrane 446 461 cytoplasmic
Input: >BPHYT_RS15500 FitnessBrowser__BFirm:BPHYT_RS15500 MNSAQQQDGLKRGLKNRHIQLIALGGAIGTGLFLGSASVLQAAGPSMILGYAIGGIIAFM IMRQLGEMVAQEPVAGSFSHFAYKYWGDFPGFLSGWNYWVLYVLVSMAELTAVGTYIHYW WPGVPTWVSALVCFALINAINLANVKAYGETEFWFAIIKVVAVIGMIVFGGYLLISGHGG PQASITNLWSHGGFFPHGFHGLFMMLAVIMFSFGGLELIGITAAEADQPQKSIPKAVNQV IYRILIFYICSLTVLLSLYPWNEVAAGGSPFVMIFSQIGSTLTANVLNVVVLTAALSVYN SGVYANSRMLYGLAEQGNAPRALMKVDRRGVPYMAIGLSALATFTCVIVNYLIPAEALGL LMALVVAALVLNWALISLTHLKSRKAMVAAGETLVFKSFWFPVSNWICLAFMALILVILA MTPGLSVSVWLVPAWLVVMWAGYVFKRRRAAVQGGARVVGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server